Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

18.470
+0.6003.36%
Volume:5.10M
Turnover:93.69M
Market Cap:48.91B
PE:12.45
High:18.610
Open:17.880
Low:17.640
Close:17.870
52wk High:26.110
52wk Low:14.505
Shares:2.65B
HK Float Shares:530.00M
Volume Ratio:2.72
T/O Rate:0.96%
Dividend:0.46
Dividend Rate:2.47%
EPS(LYR):1.483
ROE:6.95%
ROA:1.40%
PB:0.86
PE(LYR):12.45
PS:0.98

Loading ...

Fosun Pharma Maintains Stable Share Base in April; 0% New Issuance, Public Float Compliant

Bulletin Express
·
Apr 30

FOSUN PHARMA Subsidiary Receives Regulatory Approval for Sodium Nitroprusside Injection

Stock News
·
Apr 30

Fosun Pharmaceutical Reports 14% Higher Profit in Q1

MT Newswires Live
·
Apr 29

Press Release: Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution

Dow Jones
·
Apr 28

Morgan Stanley Raises Fosun Pharma's Revenue Forecast, Sets HK$32 Target with "Overweight" Rating

Stock News
·
Apr 22

FOSUN PHARMA’s 2025 ESG Report Highlights: AA MSCI Rating, RMB 5.91 Billion R&D Spend, and Strong Green, Social Commitments

Bulletin Express
·
Apr 21

Fosun Pharma Releases 2025 ESG and Sustainability Report

Bulletin Express
·
Apr 21

复星医药2025年报:净利润同比增至33.71亿元,业务与治理结构持续优化

Bulletin Express
·
Apr 21

FOSUN PHARMA Announces Release of 2025 Annual Report and Updates Shareholder Communication Arrangements

Bulletin Express
·
Apr 21

BRIEF-Shanghai Fosun Pharma Unit Received Approval From NMPA

Reuters
·
Apr 14

Fosun Pharma Unit Gets China Nod for Amyloidosis Drug Trial

MT Newswires Live
·
Apr 14

Fosun Pharma receives NMPA green light for Phase I/II trials of dual-target CAR-T therapy FKC289

Bulletin Express
·
Apr 14

Shanghai Fosun Pharma - Unit Received Approval From Nmpa for Phase I/Ii Clinical Trial of Fkc289 Injection

THOMSON REUTERS
·
Apr 14

FOSUN PHARMA Subsidiary Receives Approval for Phase I Trial of HLX05-N Cancer Treatment

Stock News
·
Apr 14

Hong Kong Market Announcement Highlights: VGT Launches IPO with CPE Rosewood and Janchor Fund as Cornerstone Investors

Stock News
·
Apr 13

BRIEF-Shanghai Fosun Pharma Unit's Drug Registration Application For Flurbiprofen Axetil Injection Approved By NMPA

Reuters
·
Apr 10

FOSUN PHARMA's Flurbiprofen Axetil Injection Receives Marketing Authorization

Stock News
·
Apr 10

Shanghai Fosun Pharma - Unit's Drug Registration Application for Flurbiprofen Axetil Injection Approved by Nmpa

THOMSON REUTERS
·
Apr 10

Fosun Pharma Schedules 28 April Board Meeting to Review Q1 2026 Results

Bulletin Express
·
Apr 10